Vanguard Group Inc Arbutus Biopharma Corp Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Vanguard Group Inc holds 8,980,864 shares of ABUS stock, worth $30.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,980,864
Previous 8,918,582 0.7%
Holding current value
$30.7 Million
Previous $34.3 Million 14.47%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$3.18 - $4.2 $198,056 - $261,584
62,282 Added 0.7%
8,980,864 $29.4 Million
Q3 2024

Nov 13, 2024
BUY
$3.12 - $4.56 $5.92 Million - $8.65 Million
1,896,487 Added 27.01%
8,918,582 $34.3 Million
Q2 2024

Aug 13, 2024
BUY
$2.52 - $3.63 $2.61 Million - $3.75 Million
1,034,188 Added 17.27%
7,022,095 $21.7 Million
Q1 2024

May 10, 2024
SELL
$2.26 - $2.92 $2,205 - $2,849
-976 Reduced 0.02%
5,987,907 $15.4 Million
Q4 2023

Feb 14, 2024
BUY
$1.69 - $2.54 $69,055 - $103,786
40,861 Added 0.69%
5,988,883 $15 Million
Q3 2023

Nov 14, 2023
BUY
$1.9 - $2.27 $244,469 - $292,076
128,668 Added 2.21%
5,948,022 $12.1 Million
Q2 2023

Aug 14, 2023
BUY
$2.24 - $3.06 $399,060 - $545,145
178,152 Added 3.16%
5,819,354 $13.4 Million
Q1 2023

May 15, 2023
BUY
$2.23 - $3.1 $615,874 - $856,148
276,177 Added 5.15%
5,641,202 $17.1 Million
Q4 2022

Feb 10, 2023
BUY
$1.91 - $2.85 $189,359 - $282,551
99,141 Added 1.88%
5,365,025 $12.5 Million
Q3 2022

Nov 14, 2022
BUY
$1.88 - $2.88 $121,231 - $185,716
64,485 Added 1.24%
5,265,884 $10.1 Million
Q2 2022

Aug 12, 2022
BUY
$1.98 - $3.17 $917,177 - $1.47 Million
463,221 Added 9.78%
5,201,399 $14.1 Million
Q1 2022

May 13, 2022
BUY
$2.42 - $3.98 $442,095 - $727,082
182,684 Added 4.01%
4,738,178 $14.1 Million
Q4 2021

Feb 14, 2022
BUY
$3.11 - $4.61 $2.46 Million - $3.64 Million
789,515 Added 20.96%
4,555,494 $17.7 Million
Q3 2021

Nov 12, 2021
BUY
$2.65 - $4.62 $78,826 - $137,426
29,746 Added 0.8%
3,765,979 $16.2 Million
Q2 2021

Aug 13, 2021
BUY
$2.5 - $3.51 $9.34 Million - $13.1 Million
3,736,233 New
3,736,233 $11.3 Million

Others Institutions Holding ABUS

# of Institutions
165
Shares Held
102M
Call Options Held
649K
Put Options Held
666K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $513M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email